AU2003261756A1 - Acrylamide derivatives - Google Patents

Acrylamide derivatives

Info

Publication number
AU2003261756A1
AU2003261756A1 AU2003261756A AU2003261756A AU2003261756A1 AU 2003261756 A1 AU2003261756 A1 AU 2003261756A1 AU 2003261756 A AU2003261756 A AU 2003261756A AU 2003261756 A AU2003261756 A AU 2003261756A AU 2003261756 A1 AU2003261756 A1 AU 2003261756A1
Authority
AU
Australia
Prior art keywords
acrylamide derivatives
acrylamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261756A
Inventor
Miyuki Funahashi
Takayuki Imaoka
Masanobu Kaneeda
Masayuki Kaneko
Hirokazu Kubota
Koichiro Morihira
Tatsuaki Morokata
Ippei Sato
Masaki Yokota
Kazuhiro Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Toray Industries Inc
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2002248660A external-priority patent/JP2004083511A/en
Priority claimed from JP2003091009A external-priority patent/JP2006076884A/en
Application filed by Toray Industries Inc, Yamanouchi Pharmaceutical Co Ltd filed Critical Toray Industries Inc
Publication of AU2003261756A1 publication Critical patent/AU2003261756A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2003261756A 2002-08-28 2003-08-27 Acrylamide derivatives Abandoned AU2003261756A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002248660A JP2004083511A (en) 2002-08-28 2002-08-28 Acrylamide derivative
JP2002-248660 2002-08-28
JP2003091009A JP2006076884A (en) 2003-03-28 2003-03-28 Acrylamide derivative
JP2003-91009 2003-03-28
PCT/JP2003/010845 WO2004022535A1 (en) 2002-08-28 2003-08-27 Acrylamide derivatives

Publications (1)

Publication Number Publication Date
AU2003261756A1 true AU2003261756A1 (en) 2004-03-29

Family

ID=31980498

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261756A Abandoned AU2003261756A1 (en) 2002-08-28 2003-08-27 Acrylamide derivatives

Country Status (2)

Country Link
AU (1) AU2003261756A1 (en)
WO (1) WO2004022535A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004023507A1 (en) 2004-05-10 2005-12-01 Grünenthal GmbH Substituted cyclohexylacetic acid derivatives
SI1877379T1 (en) * 2005-04-13 2013-05-31 Astex Therapeutics Limited Hydroxybenzamide derivatives and their use as inhibitors of hsp90
CA2665195C (en) * 2006-10-11 2011-08-09 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use thereof
US20100048633A1 (en) * 2007-01-31 2010-02-25 Philipp Lehr Piperidine-4-acrylamides
WO2008150470A1 (en) 2007-05-31 2008-12-11 Shionogi & Co., Ltd. Oxyimino compounds and the use thereof
JP5501983B2 (en) 2008-06-11 2014-05-28 塩野義製薬株式会社 Oxycarbamoyl compounds and uses thereof
CA2757726A1 (en) * 2009-04-02 2010-10-07 Shionogi & Co., Ltd. Acrylamide compounds and the use thereof
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc Urea derivatives which can be used to treat cancer
WO2024018354A1 (en) * 2022-07-18 2024-01-25 Pi Industries Ltd. A process for the synthesis of 4-alkoxy-3-hydroxypicolinic acids and intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1171350A (en) * 1997-06-17 1999-03-16 Takeda Chem Ind Ltd Hydroxypiperidine compound and agent thereof
WO2002018335A1 (en) * 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Cyclic amine derivatives

Also Published As

Publication number Publication date
WO2004022535A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003281040A1 (en) Biaryl derivatives
AU2003220935A1 (en) Benzamide derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) Azaarene derivatives
AU2003211362A1 (en) N-hydroxycarboxamide derivative
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003261756A1 (en) Acrylamide derivatives
AU2003231370A1 (en) Amide derivatives
AU2003235889A1 (en) Amide derivatives
EP1531854A4 (en) O-derivatized nocathiacin derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003238180A1 (en) 2-naphtamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase